ELAM-1 antagonists (ISIS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameELAM-1 antagonists (ISIS)
Drug Alias NameISIS-4730
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSelectins modulators
TargetsSelectins
Therapy Area/IndicationsInflammationColonic NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonis Pharmaceuticals IncBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive IndicationsInflammationColonic NeoplasmsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A